For instance, in breast cells, LINC00665 was shown to encode for a micropeptide of 5.5 kDa named CIP2A-BP, which binds CIP2A and competes with the subunit PP2A, an oncogene that promotes tumor progression [31]. This evidence concerns the gene CIP2A and neoplasm.